-
Study aim
-
Determining the effect of atropine 0.025% on the angle of deviation and indices of accommodation and vergence system in students aged 18 to 25 years.
-
Design
-
A controlled, parallel-group, single-blind, randomized, phase 3 clinical trial on 42 individuals aged 18 to 25 years.
-
Settings and conduct
-
Faculty students with age range of 18 to 25 years who meet the study entry and exit criteria and have completed the consent form are included in this study and their examinations are done in the faculty clinic. In the intervention group, 0.025% atropine are poured every night before going to bed at a specific time, and the control group is asked to use artificial tear drops in the same way. In order to blind, atropine drops are poured into artificial tear containers so that people are blind in terms of the type of drop. Visual acuity, refractive error, and all indicators of the accommodation and vergence system will be measured and compared before and one week after the intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: person with 18 to 25 years, best corrected visual acuity of 20/20, Normal binocular vision
Exclusion criteria: history of eye symptoms caused by close work, diplopia or blurred vision, history of strabismus, amblyopia or pathological eye diseases
-
Intervention groups
-
This study includes two groups. One group drop 0.025% atropine in each eye every night and is the intervention group, which is supposed to investigate the effect of this drug on all aspects of the vergence and accommodation system. The second group is the control group, who put one drop of artificial tears in each eye every night.
-
Main outcome variables
-
The amount of changes in the amplitude of accommodation , the amount of ocular deviation in far and near